1. Home
  2. EXP vs GKOS Comparison

EXP vs GKOS Comparison

Compare EXP & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Materials Inc

EXP

Eagle Materials Inc

HOLD

Current Price

$186.11

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$96.44

Market Cap

6.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXP
GKOS
Founded
1963
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
6.9B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
EXP
GKOS
Price
$186.11
$96.44
Analyst Decision
Hold
Strong Buy
Analyst Count
9
14
Target Price
$226.44
$133.07
AVG Volume (30 Days)
406.6K
678.3K
Earning Date
04-29-2026
05-14-2026
Dividend Yield
0.54%
N/A
EPS Growth
1.18
N/A
EPS
11.21
N/A
Revenue
$495,023,000.00
$507,442,000.00
Revenue This Year
$1.84
$23.39
Revenue Next Year
$1.69
$27.46
P/E Ratio
$16.63
N/A
Revenue Growth
N/A
32.33
52 Week Low
$185.50
$73.16
52 Week High
$243.64
$130.23

Technical Indicators

Market Signals
Indicator
EXP
GKOS
Relative Strength Index (RSI) 25.52 28.21
Support Level N/A $93.96
Resistance Level $240.80 $97.00
Average True Range (ATR) 7.04 3.77
MACD -3.86 -2.37
Stochastic Oscillator 4.38 1.28

Price Performance

Historical Comparison
EXP
GKOS

About EXP Eagle Materials Inc

Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: